ESMO Open is the European Society for Medical Oncology’s online-only, peer-reviewed open access journal, dedicated to publishing high-quality medical research and educational content from all disciplines of oncology, with a focus on innovative clinical and translational cancer research.
Aims and scope
The journal aims to publish research in all disciplines, experimental, translational, diagnostic and therapeutic areas related to oncology, including: original articles, reviews, editorials and correspondence. In addition the journal welcomes study protocols, phase I trials and meta-analyses, and will also publish reviews from important European Society for Medical Oncology (ESMO) conferences and meetings as well as position statements on behalf of ESMO.
ESMO Open aims to operate a fast submission process with continuous publication online, to ensure that timely, up-to-date research is available worldwide and adheres to a rigorous and transparent peer review process. ESMO Open adheres to the highest possible industry standards concerning publication ethics. To read the journal’s detailed guidelines please see our policies.
With the widest possible reach and an international editorial board of experts and key opinion leaders, the journal aims to rapidly disseminate the best in innovative clinical and translational cancer research and improve the quality of education, prevention, diagnosis, treatment and patient care worldwide.
ESMO Open is published by BMJ on behalf of European Society for Medical Oncology.
|Publication Model||Open access|
|Frequency||Continuous online publication|
|Indexed by||PubMed Central, ESCI, Google Scholar|
|Peer review model||Single blind; the names of reviewers are hidden from the author|
Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.
Annals of Oncology is a multidisciplinary journal that publishes articles addressing medical oncology, surgery, radiotherapy, paediatric oncology, basic research and the comprehensive management of patients with malignant diseases.
ESMO Open is owned by the European Society for Medical Oncology and published by the BMJ Publishing Group Ltd, a wholly owned subsidiary of the British Medical Association. The owners grant editorial freedom to the Editor of ESMO Open. ESMO Open follows guidelines on editorial independence produced by the World Association of Medical Editors and the code on good publication practice of the Committee on Publication Ethics.
ESMO Open is intended for medical professionals and is provided without warranty, express or implied. Statements in the Journal are the responsibility of their authors and advertisers and not authors’ institutions, the European Society for Medical Oncology, the BMJ Publishing Group Ltd or the British Medical Association unless otherwise specified or determined by law. Acceptance of advertising does not imply endorsement. To the fullest extent permitted by law, the European Society for Medical Oncology and the BMJ Publishing Group Ltd shall not be liable for any loss, injury or damage resulting from the use of ESMO Open or any information in it whether based on contract, tort or otherwise. Readers are advised to verify any information they choose to rely on.
© 2018 European Society for Medical Oncology. All rights reserved; no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the European Society for Medical Oncology and the BMJ Publishing Group Ltd.
Dryad is an international repository of data underlying peer-reviewed articles in the basic and applied biosciences. Dryad enables scientists to validate published findings, explore new analysis methodologies, repurpose data for research questions unanticipated by the original authors, and perform synthetic studies. BMJ has been working with Dryad since 2010.
The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. The BMJ Publishing Group has been a member since 2009.
Open Access articles in ESMO Open are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) license. These licenses let others distribute, remix, tweak and build upon your work.